
NeuroPace NPCE Surges 9.1%: Is There More Upside for This Stock?
NeuroPace (NPCE): A Surge in Shares and Earnings Estimate Revisions NeuroPace, Inc. (NPCE), a medical device company specializing in the development of implantable neurostimulation systems for the treatment of epilepsy and Parkinson’s disease, saw a notable surge in its shares during the last trading session. The company’s stock price experienced a significant increase, outpacing the…